Efficient and Heritable Gene Targeting in Tilapia by CRISPR/Cas9

Abstract

Studies of gene function in non-model animals have been limited by the approaches available for eliminating gene function. The CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR associated) system has recently become a powerful tool for targeted genome editing. Here, we report the use of the CRISPR/Cas9 system to disrupt selected genes, including nanos2, nanos3, dmrt1, and foxl2, with efficiencies as high as 95%. In addition, mutations in dmrt1 and foxl2 induced by CRISPR/Cas9 were efficiently transmitted through the germline to F 1 . Obvious phenotypes were observed in the G0 generation after mutation of germ cell or somatic cell-specific genes. For example, loss of Nanos2 and Nanos3 in XY and XX fish resulted in germ cell-deficient gonads as demonstrated by GFP labeling and Vasa staining, respectively, while masculinization of somatic cells in both XY and XX gonads was demonstrated by Dmrt1 and Cyp11b2 immunohistochemistry and by up-regulation of serum androgen levels. Our data demonstrate that targeted, heritable gene editing can be achieved in tilapia, providing a convenient and effective approach for generating loss-of-function mutants. Furthermore, our study shows the utility of the CRISPR/Cas9 system for genetic engineering in non-model species like tilapia and potentially in many other teleost species. R ECENTLY, a simple and efficient genome editing technology, type II CRISPR/Cas9, has been developed based on the Streptococcus pyogenes clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein (Cas9) adaptive immune system. It requires three components for effective DNA cleavage: the nuclease Cas9, a targeting CRISPR RNA (crRNA), and an additional transactivating crRNA (tracrRNA) (Gasiunas et al. 2012;Jinek et al. 2012;Cho et al. 2013;Cong et al. 2013;Hwang et al. 2013;Mali et al. 2013). Further improvement of the system was achieved by fusing the crRNA and tracrRNA to form a single guide RNA (gRNA) that is sufficient to direct Cas9-mediated target cleavage (Hwang et al. 2013). Importantly, previous studies performed in vitro (Jinek et al. 2012), in bacteria , and in human cells (Cong et al. 2013) have shown that Cas9-mediated cleavage can be abolished by single mismatch at the gRNA-target site interface, particularly in the last 10-12 nucleotides located in the 39 end of the 20-nt gRNA targeting region. Compared to the other two engineered nuclease genome-editing technologies, zinc-finger nucleases (ZFNs) (Urnov et al. 2005;Doyon et al. 2008) and transcription activator-like effector nucleases (TALENs) (Huang et al. 2011;Sander et al. 2011;Tesson et al. 2011), the CRISPR/Cas9 system is substantially less expensive and much easier to program for editing new target sites. This new approach has been widely used for genome engineering in model animals, including Caenorhabditis elegans (Dickinson et al. 2013;Friedland et al. 2013;Tzur et al. 2013), Drosophila (Bassett et al. 2013;Ren et al. 2013;Yu et al. 2013), zebrafish (Chang et al. 2013Hrusc...

Electrical synapses connect a network of gonadotropin releasing hormone neurons in a cichlid fish

“…We cannot rule out the possibility that other connexins may also contribute, or that presynaptic inputs could activate these neurons simultaneously. Nonetheless, the identification of Gjd2a provides an entrée for a genetic dissection of the basis of electrical coupling using genome modification technologies in cichlids including Tol2 and CRISPR/Cas9 (37)(38)(39)(40). Such experiments may disentangle the respective contributions to synchrony of electrical synapses and common presynaptic inputs.…”

Ancestral genomic duplication of the insulin gene in tilapia: An analysis of possible implications for clinical islet xenotransplantation using donor islets from transgenic tilapia expressing a humanized insulin gene

“…15,16,17 While these transgenic tilapia, have BBs which simultaneously secrete human and tilapia insulin, we believe that the wild-type tilapia insulin gene, like other fish genes including those of tilapia, can be silenced using CRISPR technology if required. 18,19 In anticipation of clinical islet xenotransplantation studies, we have extensively characterized tilapia BBs (cell biology, morphology, embryonic development, post embryonic growth proliferation, peptides, etc) and their regulation of glucose homeostasis; for a review see 4 . We have also extensively characterized the tilapia insulin gene (NTins1) as described elsewhere.…”

Osmolality/salinity-responsive enhancers (OSREs) control induction of osmoprotective genes in euryhaline fish

“…In addition to this candidate approach, unbiased approaches for identifying the putative OSRE1-binding protein are now feasible, e.g., pulldown assays using bead-immobilized OSRE1 sequences and identification of OSRE1-binding proteins by MS. Moreover, OSRE1-containing salinity-induced genes can now be rendered unresponsive to environmental salinity by genome editing of OSRE1 enhancers in specific target genes via CRISPR/Cas9 (112). Such an approach will allow studies of gene function in a specific environmental context (salinity stress) while retaining the constitutive expression of target genes under control conditions and eliminating concerns about embryonic lethality and developmental compensation, which are common pitfalls associated with constitutive gene knockouts in transgenic animals (113).…”